Epistem Names CEO
This article was originally published in Scrip
Epistem Holdings Plc. has appointed David Budd CEO and to its board of directors – March 1, 2016. Budd was previously general manager of Leica Biosystems Amsterdam and before this he was commercial director at Leica Biosystems Newcastle. Prior to Leica, he was director of marketing at Siemens Healthcare Diagnostics, business unit leader at Bayer Diagnostics UK, and sales manager at Visible Genetics Inc.